Loading...
http://jcps.bjmu.edu.cn

Table of Content

    30 November 2022, Volume 31 Issue 11
    Original articles
    Deciphering the latent mechanism of nobiletin in the treatment of metabolic syndrome based on network pharmacology and molecular docking
    Xiaohui Du, Hongyan Yang, Tao Wang, Hongxia Cui, Yu Lin, Hongling Li
    2022, 31(11):  803-823.  DOI: 10.5246/jcps.2022.11.069
    Asbtract ( 198 )   HTML ( 22)   PDF (13547KB) ( 76 )  
    Figures and Tables | References | Related Articles | Metrics

    Nobiletin (NOB) may have a potential effect on metabolic syndrome. In the present study, we aimed to explore the latent mechanisms of NOB for the treatment of metabolic syndrome based on network pharmacology and molecular docking methods. The potential targets of NOB were retrieved and identified from six databases, such as the Traditional Chinese Medicine Systems Pharmacology Database. The metabolic syndrome-related targets were retrieved from six databases as follows: the DrugBank database, GeneCards database, the Online Mendelian Inheritance in Man database, PharmGKB database, Therapeutic Target Database, and DisGeNet database. Gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of 60 intersected genes were performed in R software (Bioconductor, clusterProfiler) to investigate the molecular mechanisms. Subsequently, the ingredient-target-pathway network of NOB was constructed and visualized through Cytoscape 3.8.0 software. Protein-protein interaction network was constructed to screen hub genes in the treatment of NOB on metabolic syndrome through The Search Tool for the Retrieval of Interacting Genes/Proteins and visualized by Cytoscape 3.8.0 software. Afterward, molecular docking was used to analyze the score of the hub genes with NOB. Cumulatively, 105 targets of NOB were identified. Moreover, 1975 metabolic syndrome-related genes were acquired from six databases after combining and deleting the repeated items, and the overlap of metabolic syndrome-related genes with NOB-related target genes identified 60 intersection genes of NOB against metabolic syndrome. Moreover, 1858 GO entries of NOB on metabolic syndrome were identified, and 153 pathways were screened based on GO and KEGG analyses. The target hub genes of NOB in MetS treatment were TP53, MAPK8, AKT1, GSK3B, HSP90AA1, CTNNB1, JUN, AR, ESR1, CCND1, HRAS, TNF, and PPARA. It was confirmed that lipid and atherosclerosis, together with the AGE-RAGE signaling pathway in diabetic complications, were putatively critical pathways of NOB in the treatment of metabolic syndrome. The molecular docking results revealed that most of 13 hub genes had a strong binding to NOB. Due to the versatile actions of NOB, it had the potential action on metabolic syndrome by multiple targets and multiple pathways.

    Dihydromyricetin improves liver fat deposition in high-fat diet-induced obese mice
    Huijie Lv, Tuo Xv, Jun Peng, Gang Luo, Jianqin He, Sisi Yang, Tiancheng Zhang, Shuidong Feng, Hongyan Ling
    2022, 31(11):  824-839.  DOI: 10.5246/jcps.2022.11.070
    Asbtract ( 224 )   HTML ( 7)   PDF (3705KB) ( 57 )  
    Figures and Tables | References | Related Articles | Metrics

    It has been reported that the histone/protein deacetylase SIRT1-AMP-activated protein kinase (SIRT1-AMPK) signaling pathway may play a role in the effects of dihydromyricetin (DHM) on improving triglyceride (TG) accumulation and insulin resistance in liver cells. Therefore, we aimed to further observe the effect of DHM on liver fat deposition in high-fat diet (HFD)-induced obese mice and explore its possible mechanism. C57BL/6J mice were fed with a normal diet (ND) and HFD and were treated with or without low-dose (125 mg/kg) or high-dose (250 mg/kg) DHM for 16 weeks, respectively. During the experiment, body weight was checked every 2 weeks. After 16 weeks, the orbital vein was bled, the animals were sacrificed, and the subscapular, epididymal, and inguinal fat were collected and weighed with an electronic scale. An automatic biochemical analyzer was used to determine the levels of serum triglyceride (TG), serum total cholesterol (TC), serum high-density lipoprotein (HDL), and serum low-density lipoprotein (LDL). The livers were stained with hematoxylin-eosin staining (H&E) and Oil Red O to detect liver fat deposition. A colorimetric method was used to detect liver MDA and SOD contents. Quantitative real-time PCR (qRT-PCR) was used to detect the gene expressions of related indicators, such as interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α), acetyl-CoA carboxyl acetyl-CoA carboxylase (ACC), sterol regulatory element-binding protein-1c (SREBP-1), fatty acid synthetase (FAS), peroxisome proliferator activation receptor alpha (peroxisome proliferator-activated receptor-alpha, PPARα), palmitoyltransferase 1 (carnitine palmitoyltransferase 1, CPT1), SIRT1, and AMPK. Western blotting analysis was used to detect the protein expression levels of SIRT1, AMPK, SIRT1-AMPK, ACC, SREBP-1, FAS, PPARα, and CPT1. Results showed that compared with the ND group, the weight and body fat of the mice in the HFD group were increased significantly. The levels of TG, TC, and LDL were increased, the level of HDL was decreased, the volume of hepatocytes was increased, the number of lipid droplets, fat deposition, MDA, IL-6, IL-8, TNF-α, SREBP-1c, FAS, ACC1, SIRT1, and AMPK protein levels were significantly increased, and the SOD activity, PPARα, CPT1, SIRT1 mRNA, AMPK mRNA, PPARα, CPT1 levels were significantly decreased. DHM could significantly reverse the changes of the above indexes in HFD mice, while DHM had no significant effect on the above indexes in ND mice. Collectively, our findings revealed that DHM improved liver fat deposition in HFD-induced obese mice, and the mechanism might be related to inhibition of oxidative stress, inflammation, lipid synthesis, and promotion of lipid decomposition.

    The alleviating effect of quercetin on carbon tetrachloride-induced liver fibrosis in rats and its underlying mechanism
    Mingkang Zhang, Yuyue Chen, Yan Zhou, Xin'an Wu
    2022, 31(11):  840-852.  DOI: 10.5246/jcps.2022.11.071
    Asbtract ( 314 )   HTML ( 5)   PDF (5491KB) ( 45 )  
    Figures and Tables | References | Related Articles | Metrics

    Quercetin, a phenolic phytochemical widely present in vegetables and fruits, has antioxidant, anti-inflammatory, antiviral, and immunomodulatory activities, and it has been successfully used in the treatment of acute and chronic diseases. In the present study, we aimed to investigate the alleviation effect of quercetin on rat liver fibrosis and explore its mechanism of action. Healthy male SD rats were randomly divided into the normal group, model group, and quercetin group, with six rats in each group. Liver fibrosis was induced by intraperitoneal injection of 1 mL/kg carbon tetrachloride (50% v/v in olive oil) twice a week for 6 weeks, and quercetin (100 mg/kg/d) was administered orally in the 7th week until the end of the 12th week. Blood and liver samples were collected at 1 h after the last administration. Serum liver function parameters (AST, ALT, ALP, GGT, and TBA) were detected by an automatic biochemical analyzer. H&E, Masson, and Sirius red staining were used to observe the pathological morphology of liver tissue. Western blotting analysis was used to evaluate the expressions of liver fibrotic factors (TGF-β1, α-SMA, MMP2, and MMP9) and bile acid-related regulatory proteins (FXR, CYP7A1, CYP8B1, and CYP27A1). The oxidative stress markers (GSH, GSH-Px, GR, SOD, and MDA) in the liver tissue were detected using corresponding kits. The contents of bile acids in the liver tissue were determined by LC-MS/MS. The results showed that compared with the model group, quercetin treatment could significantly reduce serum AST, ALT, and TBA levels (P < 0.05). The fibrotic liver injury was significantly improved, and the expressions of fibrotic factors TGF-β1, α-SMA, MMP2, and MMP9 were significantly decreased (P < 0.05). Liver GSH, GSH-Px, GR, and SOD levels were significantly increased (P < 0.05), and the MDA level was significantly decreased (P < 0.05). The contents of hepatic bile acids were significantly decreased (P < 0.05), the expression of FXR was significantly increased (P < 0.05), and the expressions of CYP7A1 and CYP8B1 were significantly decreased (P < 0.05). This study suggested that quercetin could effectively alleviate carbon tetrachloride-induced liver fibrosis injury, and its mechanism of action was related to improving the liver’s ability to resist oxidative stress and reducing the expressions of fibrotic factors and bile acid synthesis.

    Efficacy and safety of ACEI plus tanshinone for acute exacerbation of pulmonary heart disease: a meta-analysis
    Min Li, Lulu Chang, Xiangfeng Yue, Shuzhang Du
    2022, 31(11):  853-865.  DOI: 10.5246/jcps.2022.11.072
    Asbtract ( 189 )   HTML ( 8)   PDF (5383KB) ( 20 )  
    Figures and Tables | References | Related Articles | Metrics

    Acute exacerbation of pulmonary heart disease (AECPHD) is life-threatening. Conventional therapy plus angiotensin-converting enzyme inhibitors (ACEI) is not always practical. Recent trials have suggested the beneficial effects of the combination of ACEI and tanshinone on AECPHD. In the present study, we aimed to evaluate its efficacy and safety by meta-analysis systematically. The result indicated that combination of ACEI and tanshinone was more effective than ACEI monotherapy in AECPHD, as represented by treatment efficiency and mean pulmonary arterial pressure, PaCO2, and PaO2. However, the incidence of adverse events of combined therapy was higher than the control group, while the result of the analysis for adverse events was unstable. Further large-scale, multicenter, and rigorously designed randomized controlled trials (RCT) are needed to evaluate the efficacy and safety of combined therapy.

    Exploration of collaborative drug therapy management mode for elderly patients with chronic diseases
    Shuyun Feng, Pengju Chen, Ning Wang, Bo Zhao, Yifan Lu, Yongheng Zhang
    2022, 31(11):  866-876.  DOI: 10.5246/jcps.2022.11.073
    Asbtract ( 180 )   HTML ( 3)   PDF (1725KB) ( 26 )  
    References | Related Articles | Metrics

    As China is accelerating into an aging society, the coexistence of multiple diseases, multiple drugs, and the decline of body function are serious problems faced by elderly patients. Therefore, it is imperative to carry out the comprehensive prevention and control of chronic diseases, strengthen the health guidance and comprehensive intervention of common and chronic diseases of the elderly, and strengthen the health management of elderly patients. Collaborative drug therapy management (CDTM) is a drug treatment management mode that emerged in pharmaceutical services under the situation of new medical reform, aiming to expand the role of pharmacists in the medical team and improve the quality of hospital medical service. Although CDTM has shown some favorable effects in managing chronic diseases in the elderly population, the popularization of CDTM in China is limited by the differences in supporting facilities, management mode, and pharmacist's abilities in hospitals. By exploring the CDTM mode for elderly patients with chronic diseases, we provided a reference for further promoting the CDTM services and laid a good foundation for displaying pharmacist value and the realization of real pharmaceutical care.

    Hepatic safety of caspofungin during treatment of fungal diseases in neonates
    Gaole Yuan, Yingqiu Tu, Weiwei Yan, Fang Wang
    2022, 31(11):  877-882.  DOI: 10.5246/jcps.2022.11.074
    Asbtract ( 191 )   HTML ( 3)   PDF (1519KB) ( 17 )  
    Figures and Tables | References | Related Articles | Metrics

    The use of caspofungin in neonates is beyond the instructions. Therefore, a retrospective analysis was performed to investigate the hepatic safety of caspofungin during the treatment of fungal diseases in neonates. A retrospective analysis was conducted on 23 neonates with Candida infection who were treated or prevented with caspofungin. Among the 23 neonates treated with caspofungin, 13 cases were cured (57%), and 10 cases showed improvements (43%). In addition, there were no adverse reactions associated with drug use, such as gastrointestinal tract, thrombocytopenia, and liver function damage. In summary, caspofungin achieved good results in the treatment or prevention of Candida infection in neonates, and no severe adverse reactions closely related to its use were found. However, the economy and safety of antifungal drugs should be considered in clinical practice for reasonable use.

    Study on drug synthesis and activity of sodium olpadronate
    Yuehua Liu, Zhangqin Xue, Jianming Wei, Ruomeng Wei, Baodong Yin, Aiqin Liu
    2022, 31(11):  883-892.  DOI: 10.5246/jcps.2022.11.075
    Asbtract ( 211 )   HTML ( 8)   PDF (2082KB) ( 37 )  
    Figures and Tables | References | Related Articles | Metrics

    As a systemic metabolic disease caused by a variety of factors, osteoporosis is characterized by reduced bone mass, bone tissue microstructural degradation, and decreased bone mechanical properties, accompanied by bone fragility and fracture, which is a common risk of senile disease. In China, osteoporosis has become a common disease and has frequent morbidity, with the incidence trend on the rise. Bisphosphates have received much attention in this field as inhibitory bone resorption agents, and sodium olpadronate belongs to the third-generation bisphosphonates. This experiment investigated the synthetic process and pharmacological activity of sodium olpadronate. Using 3-(N,N-dimethylamino)-propionitrile as the starting material, the synthesis process was improved to reduce cost with a total yield of 49.7%, which was 24.0% higher than that reported in the literature. Pharmacodynamic experiments showed that sodium olpadronate could be used to treat osteoporosis. Moreover, toxicology experiments showed no obvious toxic side effects. Taken together, sodium olpadronate had very promising development prospects.

    News
    The research group of Prof. Jing Wang developed the detection method of m6A single base quantitative sequencing
    State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
    2022, 31(11):  893-896. 
    Asbtract ( 103 )   PDF (2315KB) ( 18 )  
    Related Articles | Metrics
    The research group of Prof. Jing Wang developed the detection method of m6A single base quantitative sequencing. 
    Prof. Pengfei Tu and Prof. Kewu Zeng  have discovered the natural molecule glue bufalin
    State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
    2022, 31(11):  897-898. 
    Asbtract ( 160 )   PDF (1550KB) ( 19 )  
    Related Articles | Metrics
    Prof. Pengfei Tu and Prof. Kewu Zeng  have discovered the natural molecule glue bufalin.
    The research group of Prof. Yanxing Jia has made an important breakthrough in the field of total synthesis of natural products
    State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
    2022, 31(11):  899-900. 
    Asbtract ( 77 )   PDF (1404KB) ( 42 )  
    Related Articles | Metrics
    The research group of Prof. Yanxing Jia has made an important breakthrough in the field of total synthesis of natural products.